SEER INC. - CLASS A C

Seer Reports First Quarter 2024 Financial Results

08 May 2024 16:05:47 By Nasdaq GlobeNewswire

Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions

08 May 2024 16:03:00 By Nasdaq GlobeNewswire

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

23 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook

29 Feb 2024 16:05:12 By Nasdaq GlobeNewswire

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

21 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

06 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

01 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference

21 Dec 2023 16:05:00 By Nasdaq GlobeNewswire

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

10 Nov 2023 09:00:29 By Nasdaq GlobeNewswire

Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500

08 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

Seer Reports Third Quarter 2023 Financial Results

07 Nov 2023 16:05:08 By Nasdaq GlobeNewswire

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program

01 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023

19 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

Seer to Participate in Upcoming September Investor Conferences

08 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

Seer Reports Second Quarter 2023 Financial Results

08 Aug 2023 16:05:01 By Nasdaq GlobeNewswire

Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference

27 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

Seer to Report Second Quarter 2023 Financial Results on August 8, 2023

13 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center

07 Jun 2023 09:00:18 By Nasdaq GlobeNewswire

Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies

01 Jun 2023 09:00:00 By Nasdaq GlobeNewswire

Seer Reports First Quarter 2023 Financial Results

09 May 2023 16:05:01 By Nasdaq GlobeNewswire